

The ER/PR Assay (Breast Cancer) detects estrogen and progesterone receptors in breast tumors to help guide treatment, assess prognosis, and predict response to hormone therapy. Patients with ER-positive and/or PR-positive tumors are more likely to benefit from treatments such as Tamoxifen.
Other Name: Estrogen Receptor Assay (ER), Progesterone Receptor Assay (PR)
No patient preparation is required for this service
33 Unit C Ground Floor, Alabang–Zapote Road, Pamplona Dos, Las Piñas City
Add more services to your booking and save on multiple visits






